Clinical and imaging correlates of the multiple sclerosis impact scale in secondary progressive multiple sclerosis

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Neurology

• Publication date

  2012-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00415-011-6151-5PMID 21863390
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• *These authors contributed equally to this work.

  2012cited by this paper
• Electrophysiological correlates of behavioural changes in vigilance in vegetative state and minimally conscious state.

  2011cited by this paper
• The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability

  2010cited by this paper
• A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis

  2010cited by this paper
• Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial.

  2010cited by this paper
• Evidence for a two-stage disability progression in multiple sclerosis

  2010cited by this paper
• Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis

  2009cited by this paper
• Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures

  2009cited by this paper
• Validation of the Multiple Sclerosis International Quality of Life questionnaire

  2008cited by this paper
• Disability as an outcome in MS clinical trials

  2008cited by this paper
• The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite

  2008cited by this paper
• Longitudinal variations and predictors of increased perceived impact of multiple sclerosis, a two-year study.

  2008cited by this paper
• Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.

  2008cited by this paper
• Magnetization Transfer MRI in Multiple Sclerosis

  2007cited by this paper
• Imaging correlates of axonal swelling in chronic multiple sclerosis brains

  2007cited by this paper
• MRI T2 lesion burden in multiple sclerosis

  2006cited by this paper
• Cortical demyelination and diffuse white matter injury in multiple sclerosis.

  2005influential reference
• Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing.

  2005cited by this paper
• Multiple sclerosis and black holes: connecting the pixels.

  2005cited by this paper
• Unified segmentation

  2005cited by this paper
• Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change.

  2005cited by this paper
• Unified segmentation

  2005cited by this paper
• Quality of life and impairment in patients with multiple sclerosis

  2004cited by this paper
• Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability

  2004cited by this paper
• Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality

  2004cited by this paper
• A review about the impact of multiple sclerosis on health-related quality of life

  2003cited by this paper
• [Quality of life of patients with multiple sclerosis].

  2003cited by this paper
• Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance.

  2002influential reference
• Health‐related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients

  2002cited by this paper
• Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples

  2002cited by this paper
• A preliminary study of magnetization transfer and diffusion tensor MRI of multiple sclerosis patients with fatigue

  2002cited by this paper
• Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis

  2002cited by this paper
• Quality of life in patients with multiple sclerosis: the impact of fatigue and depression.

  2002cited by this paper
• Disease specific quality of life instruments in multiple sclerosis: Validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS)

  2001cited by this paper
• The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.

  2001cited by this paper
• Relapses and progression of disability in multiple sclerosis.

  2000cited by this paper
• Performance of the SF-36, SF-12, and RAND-36 Summary Scales in a Multiple Sclerosis Population

  2000cited by this paper
• Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis.

  2000cited by this paper
• The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

  2000cited by this paper
• Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability

  1999cited by this paper
• Development of a multiple sclerosis functional composite as a clinical trial outcome measure.

  1999cited by this paper
• The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment

  1999influential reference
• Visual analysis of serial T2-weighted MRI in multiple sclerosis: intra- and interobserver reproducibility

  1999cited by this paper
• Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis

  1998cited by this paper
• AXONAL TRANSECTION IN THE LESIONS OF MULTIPLE SCLEROSIS

  1998cited by this paper
• Axonal transection in the lesions of multiple sclerosis.

  1998cited by this paper
• Drug points: Acute renal failure due to rhabdomyolysis in presence of concurrent ciprofibrate and ibuprofen treatment

  1997cited by this paper
• Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression.

  1996cited by this paper
• Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

  1996cited by this paper
• DispImage: Un mezzo di analisi e presentazione per iconografia medica

  1992cited by this paper
• Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue.

  1991cited by this paper
• Rating neurologic impairment in multiple sclerosis

  1983cited by this paper
• BRAIN IMAGING: Brain MRI lesions and atrophy are related to depression in multiple sclerosis

  year unknowncited by this paper

• Correlates of patient reported quality of life in a large multiple sclerosis cohort encompassing the COVID-19 pandemic period.

  2025cites this paper
• Association between brain volume and disability over time in multiple sclerosis

  2022cites this paper
• Quantitative magnetization transfer imaging in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis

  2022cites this paper
• Rationale and design of the brain magnetic resonance imaging protocol for FutureMS: a longitudinal multi-centre study of newly diagnosed patients with relapsing-remitting multiple sclerosis in Scotland [version 1; peer review: awaiting peer review]

  2022cites this paper
• Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS

  2021cites this paper
• Rationale and design of the brain magnetic resonance imaging protocol for FutureMS: a longitudinal multi-centre study of newly diagnosed patients with relapsing-remitting multiple sclerosis in Scotland

  2021cites this paper
• Imaging and therapy in multiple sclerosis

  2020cites this paper
• Spinal Cord Atrophy in Multiple Sclerosis: A Systematic Review and Meta‐Analysis

  2018cites this paper
• Treatment of progressive multiple sclerosis: Challenges and promising perspectives.

  2018cites this paper
• Clinical trial design for progressive MS trials

  2017cites this paper
• Spinal cord atrophy in anterior‐posterior direction reflects impairment in multiple sclerosis

  2017cites this paper
• Secondary Progressive Multiple Sclerosis: Definition and Measurement

  2016cites this paper
• The role of MRI in the evaluation of secondary progressive multiple sclerosis

  2016cites this paper
• Longitudinal change in Paced Auditory Serial Addition Test (PASAT) performance following immunoablative therapy and haematopoietic stem cell transplant in multiple sclerosis

  2016cites this paper
• Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives.

  2015cites this paper
• Progressive multiple sclerosis 3 Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives

  2015cites this paper
• EXAMINING SINGLE-SUBJECT RELIABILITY OF FUNCTIONAL MAGNETIC RESONANCE IMAGING IN ESTABLISHED MULTIPLE SCLEROSIS

  2014cites this paper
• Indices of Cognitive Dysfunction in Relapsing-Remitting Multiple Sclerosis: Intra-individual Variability, Processing Speed, and Attention Network Efficiency

  2013cites this paper
• Intra-individual variability in information processing speed reflects white matter microstructure in multiple sclerosis☆

  2013cites this paper
• Multiple sclerosis imaging: recent advances

  2013cites this paper
• Noninvasive molecular imaging of neuroinflammation

  2012cites this paper
• An investigation of magnetization transfer ratio and T1 hypointense lesion volume in secondary progressive multiple sclerosis

  2012cites this paper